Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Piechaczyk

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Cell|November 20, 2002
CNF1 exploits the ubiquitin-proteasome machinery to restrict Rho GTPase activation for bacterial host cell invasionAnne Doye, Amel Mettouchi, Guillaume Bossis, et al.
Molecular and Cellular Biology|August 2, 2005
Down-regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylationGuillaume Bossis, Cécile E Malnou, Rosa Farras, et al.
Molecular Biology of the Cell|February 8, 2008
A novel role for PA28gamma-proteasome in nuclear speckle organization and SR protein traffickingVéronique Baldin, Muriel Militello, Yann Thomas, et al.
Cancer Research|March 1, 2018
Targeting the SUMO Pathway Primes All-<i>trans</i> Retinoic Acid-Induced Differentiation of Nonpromyelocytic Acute Myeloid LeukemiasHayeon Baik, Mathias Boulanger, Mohsen Hosseini, et al.
Molecular Cancer Research : MCR|July 14, 2019
AP-1 Signaling by Fra-1 Directly Regulates HMGA1 Oncogene Transcription in Triple-Negative Breast CancersClaire Tolza, Fabienne Bejjani, Emilie Evanno, et al.
Haematologica|August 23, 2023
SUMOylation inhibitor TAK-981 (subasumstat) synergizes with 5-azacytidine in preclinical models of acute myeloid leukemiaLudovic Gabellier, Marion De Toledo, Mehuli Chakraborty, et al.
Cell Reports|June 10, 2014
The ROS/SUMO axis contributes to the response of acute myeloid leukemia cells to chemotherapeutic drugsGuillaume Bossis, Jean-Emmanuel Sarry, Chamseddine Kifagi, et al.
Haematologica|February 17, 2022
The NADPH oxidase NOX2 is a marker of adverse prognosis involved in chemoresistance of acute myeloid leukemiasRosa Paolillo, Mathias Boulanger, Pierre Gâtel, et al.
Genome Biology|December 10, 2022
New roles for AP-1/JUNB in cell cycle control and tumorigenic cell invasion via regulation of cyclin E1 and TGF-β2Beatriz Pérez-Benavente, Alihamze Fathinajafabadi, Lorena de la Fuente, et al.
Cancer Research|July 31, 2019
Targeting Myeloperoxidase Disrupts Mitochondrial Redox Balance and Overcomes Cytarabine Resistance in Human Acute Myeloid LeukemiaMohsen Hosseini, Hamid Reza Rezvani, Nesrine Aroua, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Cell|November 20, 2002
CNF1 exploits the ubiquitin-proteasome machinery to restrict Rho GTPase activation for bacterial host cell invasionAnne Doye, Amel Mettouchi, Guillaume Bossis, et al.
Molecular and Cellular Biology|August 2, 2005
Down-regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylationGuillaume Bossis, Cécile E Malnou, Rosa Farras, et al.
Molecular Biology of the Cell|February 8, 2008
A novel role for PA28gamma-proteasome in nuclear speckle organization and SR protein traffickingVéronique Baldin, Muriel Militello, Yann Thomas, et al.
Cancer Research|March 1, 2018
Targeting the SUMO Pathway Primes All-<i>trans</i> Retinoic Acid-Induced Differentiation of Nonpromyelocytic Acute Myeloid LeukemiasHayeon Baik, Mathias Boulanger, Mohsen Hosseini, et al.
Molecular Cancer Research : MCR|July 14, 2019
AP-1 Signaling by Fra-1 Directly Regulates HMGA1 Oncogene Transcription in Triple-Negative Breast CancersClaire Tolza, Fabienne Bejjani, Emilie Evanno, et al.
Haematologica|August 23, 2023
SUMOylation inhibitor TAK-981 (subasumstat) synergizes with 5-azacytidine in preclinical models of acute myeloid leukemiaLudovic Gabellier, Marion De Toledo, Mehuli Chakraborty, et al.
Cell Reports|June 10, 2014
The ROS/SUMO axis contributes to the response of acute myeloid leukemia cells to chemotherapeutic drugsGuillaume Bossis, Jean-Emmanuel Sarry, Chamseddine Kifagi, et al.
Haematologica|February 17, 2022
The NADPH oxidase NOX2 is a marker of adverse prognosis involved in chemoresistance of acute myeloid leukemiasRosa Paolillo, Mathias Boulanger, Pierre Gâtel, et al.
Genome Biology|December 10, 2022
New roles for AP-1/JUNB in cell cycle control and tumorigenic cell invasion via regulation of cyclin E1 and TGF-β2Beatriz Pérez-Benavente, Alihamze Fathinajafabadi, Lorena de la Fuente, et al.
Cancer Research|July 31, 2019
Targeting Myeloperoxidase Disrupts Mitochondrial Redox Balance and Overcomes Cytarabine Resistance in Human Acute Myeloid LeukemiaMohsen Hosseini, Hamid Reza Rezvani, Nesrine Aroua, et al.
Pageof 7